Clinical trial
Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic…
NCT00031824 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00031824 |
|---|---|
| Title | Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease |
| Official title | Phase III Trial of Hydroxychloroquine + Standard Therapy for Chronic Graft-Versus-Host Disease |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease |
| Intervention type | Drug |
| Interventions | cyclosporine, hydroxychloroquine, prednisone, tacrolimus |
| Enrollment | 82 |
| Start date | Apr 1, 2002 |
| Primary completion | May 1, 2005 |
| Completion | Jan 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 14, 2014 |
| Countries | Australia, Canada, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: